Health Care: Drugs

Idenix Pharmaceuticals Inc. (IDIX: NASDAQ)

$5.46 n/a | n/a%
04/17/14 - 04:00 PM ET
Company Income Statement
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Sales 469.00K 69.66M 6.95M 10.22M
Cost of Sales 715.00K 2.65M 2.32M 2.76M
Gross Operating Profit -246.00K 67.01M 4.63M 7.46M
Selling, General, and Administrative Expenses 35.32M 24.16M 16.69M 23.44M
Research & Development 84.25M 70.18M 41.34M 44.51M
Operating Income before D & A (EBITDA) -119.82M -27.34M -53.41M -60.49M
Depreciation & Amortization 1.72M 3.10M 4.20M 4.58M
Interest Income 0.00 0.00 0.00 0.00
Other Income - Net 1.35M 2.89M 1.37M 1.13M
Special Income / Charges 0.00 -8.04M 0.00 0.00
Total Income Before Interest Expenses (EBIT) -124.09M -35.59M -56.24M -66.17M
Interest Expense 0.00 0.00 0.00 0.00
Pre-Tax Income -124.09M -35.59M -56.24M -66.17M
Income Taxes -83.00K -89.00K -61.00K -40.00K
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -122.29M -32.40M -51.98M -61.56M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -122.29M -32.40M -51.98M -61.56M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -122.29M -32.40M -51.98M -61.56M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-118.39M -24.36M -51.98M -59.32M
Preferred Dividends
Net Income Available To Common -122.29M -32.40M -51.98M -61.56M
Basic EPS from Continuing Ops. -0.91 -0.27 -0.57 -0.87
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -0.91 -0.27 -0.57 -0.87
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -0.91 -0.27 -0.57 -0.87
Basic Normalized Net Income/Share -0.88 -0.21 -0.57 -0.84
EPS fr Continuing Ops. -0.91 -0.27 -0.57 -0.87
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -0.91 -0.27 -0.57 -0.87
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -0.91 -0.27 -0.57 -0.87
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-0.88 -0.21 -0.57 -0.84
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with IDIX

Latest IDIX Headlines from TheStreet

More Financial News for IDIX

Press Releases for IDIX

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter